Alpha-tACS targeting the mPFC, reduced clinical severity of OCD compared to sham stimulation. The progress of non-invasive neurotech in biomedical applications is undeniable. #neuroscience #BCI #medicine #OCD https://t.co/x5LxKAnHjr https://t.co/C9uU3nRv
RT @Brain_Products: This randomized, double-blind, sham-controlled study suggests that noninvasive treatment with individualized alpha-tran…
This randomized, double-blind, sham-controlled study suggests that noninvasive treatment with individualized alpha-transcranial alternating current stimulation (tACS) targeting the medial prefrontal cortex (mPFC) is capable of improving OCD symptoms. 👉 ht
Check out the study by @PrabhaviPerera et al. out of The Australian National University (@ourANU) here 🧠👇 https://t.co/drFZupyZof